Use of the non-adjuvanted influenza A H1N1 vaccine was shown to be safe and efficacious in patients with systemic sclerosis.
For the 2017-18 season, quadrivalent and trivalent influenza vaccines will be available; live attenuated influenza vaccine is not recommended for use.
Zanamivir is a neuraminidase inhibitor approved in the United States as an oral inhalation powder for acute, uncomplicated influenza in children ≥7 years of age and prophylaxis in children ≥5 years of age.
Temporary cessation of methotrexate after receiving the influenza vaccine improves the immunogenicity of vaccination in patients with rheumatoid arthritis.
An investigational H1 influenza oral tablet vaccine provides similar protection against influenza as an injectable vaccine.
A highly pathogenic H7N9 avian influenza variant has evolved and now has the potential to cause a pandemic
The has expanded the use of Rapivab to pediatric patients aged ≥2 years with acute uncomplicated influenza
Digital immunoassays and rapid nucleic acid amplification tests have higher sensitivities for detecting influenza than rapid influenza diagnostic tests.
The NFID urges those 65 and older to receive their annual influenza vaccination to protect against the flu.
Pregnant women who received vaccines containing the pH1N1 antigen for 2 consecutive influenza seasons may have increased risk for spontaneous abortion 28 days postvaccination.
Only 78% of health care personnel and only 53.6% of pregnant women received influenza vaccination during the 2016-2017 influenza season.
Infantile sepsis evaluations vary considerably and could benefit from the development of an updated, standardized guideline.
A higher dose of the flu vaccine provided better protection against respiratory and all-cause hospital admissions.
The ACIP issued new guidelines for the upcoming influenza season including not using live attenuated influenza vaccine because of concerns of effectiveness.
Influenza vaccination is recommended annually because of antigenic drift, which warrants the change of influenza vaccine on a year-to-year basis.
Both trivalent and quadrivalent formulations of the influenza vaccine will be offered by Seqirus, which were developed using egg- and cell-based technologies.
The flu vaccine may have benefits by reducing negative outcomes and mortality associated with contracting influenza.
The live attenuated influenza vaccine was ineffective among children between 2 and 17 years of age during the 2015-2016 season.
Improving the rates of children and adult influenza vaccination could improve public health drastically.
Prior influenza vaccination predicts higher baseline antibody titers and decreased peak antibody responses against all influenza strains in pregnant women.
Influenza vaccination during pregnancy decreases infant hospitalizations for all-cause acute lower respiratory tract infection during the first 3 months of life.
Sanofi Pasteur announced that the first doses of Fluzone for the upcoming 2017-2018 influenza season have been shipped.
A newly identified genetic polymorphism was associated with increased rates of mortality and severe clinical outcomes from influenza infection and lower levels of resident lung CD8+ T cells, particularly in individuals of European descent.
The FDA has approved the concomitant use of varicella zoster vaccine and inactivated trivalent and quadrivalent influenza vaccines.
Clinician communication in recommending influenza vaccination in children impacts parental vaccine decision-making.
An experimental microneedle patch has demonstrated the ability to safely administer an influenza vaccine.
Obesity may increase the risk of influenza and influenza-like illness.
Over 100 influenza-associated deaths in children occurred throughout the 2016-2017 flu season.
Flublok Quadrivalent, developed without the use of eggs, is a recombinant protein-based vaccine.
A designer protein stopped the influenza virus from infecting cells in culture and protected mice after being exposed to heavy doses of the virus, according to a new study.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Pediatric Outpatient Antimicrobial Stewardship: Minimizing Antibiotic Duration
- Better Detection and Treatment Needed for H pylori Infections in Children
- Are Antibiotic Stewardship Programs the Antidote to Antibiotic Overuse?
- FDA Approves New Hepatitis B Vaccine for Adults
- Strategies for Preventing Antibiotic Resistance in Acne
- Dual Regimen Provides Simple and Safe Salvage Therapy in HIV-1
- Effectiveness of Ledipasvir/Sofosbuvir for Acute HCV Infection in HIV
- Diclofenac Inferior to Norfloxacin for UTI Symptom Relief
- Legionella Linked to Most Drinking Water-Associated Outbreaks
- Preventing HCV Transmission: Utility of Needle/Syringe Programs